D-0188-2025 Class II Ongoing

Recalled by Rising Pharma Holding, Inc. — East Brunswick, NJ

Recall Details

Product Type
Drugs
Report Date
January 15, 2025
Initiation Date
December 30, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
42,527 bottles

Product Description

Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ

Reason for Recall

CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Distribution Pattern

Nationwide

Code Information

a) Lot# DT3023051A, exp. date Apr-25; b) DT3023025A, exp. date Jan-25